Skip NavigationSkip to Content

A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques

  1. Author:
    Zhang, Peng
    Narayanan, Elisabeth
    Liu, Qingbo
    Tsybovsky, Yaroslav
    Boswell, Kristin
    Ding, Shilei
    Hu, Zonghui
    Follmann, Dean
    Lin, Yin
    Miao, Huiyi
    Schmeisser, Hana
    Rogers, Denise
    Falcone, Samantha
    Elbashir, Sayda M.
    Presnyak, Vladimir
    Bahl, Kapil
    Prabhakaran, Madhu
    Chen, Xuejun
    Sarfo, Edward K.
    Ambrozak, David R.
    Gautam, Rajeev
    Martin, Malcom A.
    Swerczek, Joanna
    Herbert, Richard
    Weiss, Deborah
    Misamore, Johnathan
    Ciaramella, Giuseppe
    Himansu, Sunny
    Stewart-Jones, Guillaume
    McDermott, Adrian
    Koup, Richard A.
    Mascola, John R.
    Finzi, Andres
    Carfi, Andrea
    Fauci, Anthony S.
    Lusso, Paolo
  2. Author Address

    NIAID, Lab Immunoregulat, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.Moderna Inc, Cambridge, MA USA.Leidos Biomed Res Inc, Canc Res Technol Program, Frederick Natl Lab Canc Res, Frederick, MD USA.NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.Univ Montreal, Montreal, PQ, Canada.NIAID, Biostat Res Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.NIAID, Lab Mol Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.NIAID, Expt Primate Virol Sect, Poolesville, MD USA.Bioqual Inc, Rockville, MD USA.
    1. Year: 2021
    2. Date: Dec
  1. Journal: Nature Medicine
  2. Nature Portfolio
  3. Type of Article: Article
  4. ISSN: 1078-8956
  1. Abstract:

    An mRNA vaccine platform to prevent HIV-1 infection generated broadly neutralizing antibodies in non-human primates and protected some animals from infection, raising hope that optimization of this approach might lead to an effective HIV vaccine.

    See More

External Sources

  1. DOI: 10.1038/s41591-021-01574-5
  2. WOS: 000728466100002

Library Notes

  1. Fiscal Year: FY2021-2022
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel